BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 2 Pharmacokinetics 2 (PHA503) calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:b47338a2-c8d1-45b6-aeae-0990e03ccc5c
DTSTAMP:20250924T210622Z
DTSTART:20251002T140000Z
DTEND:20251002T150000Z
SUMMARY:PK 3.1 Introduction to the pharmacokinetics module in year 2 and pharmacokinetic Parameter Estimations preparation session
DESCRIPTION:Module - PHA503, Person delivering - Dagan and team
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:85188b32-b5a2-416f-8d46-68ba922a40c2
DTSTAMP:20250924T210622Z
DTSTART:20251007T090000Z
DTEND:20251007T100000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:7fce80e0-c612-4a45-9435-01625aa60498
DTSTAMP:20250924T210622Z
DTSTART:20251007T100000Z
DTEND:20251007T110000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:134620b0-03f9-4100-94e5-ef0f087b8bcb
DTSTAMP:20250924T210622Z
DTSTART:20251007T110000Z
DTEND:20251007T120000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:bdfefba6-61cb-43e7-adef-5a667c46a579
DTSTAMP:20250924T210622Z
DTSTART:20251017T140000Z
DTEND:20251017T150000Z
SUMMARY:PK 3.3 Pre-clinical PK and animal to human predictions
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:9ede4915-9b69-4997-9050-d634277e1f7b
DTSTAMP:20250924T210622Z
DTSTART:20251021T090000Z
DTEND:20251021T100000Z
SUMMARY:PK 3.4  Blood Brain Barrier
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:LT G
END:VEVENT
BEGIN:VEVENT
UID:41c824dd-1e61-4458-962c-73b4d3e413de
DTSTAMP:20250924T210622Z
DTSTART:20251027T100000Z
DTEND:20251027T110000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:1bad13e1-e4c8-41ad-88cd-a487a5ccc6d3
DTSTAMP:20250924T210622Z
DTSTART:20251027T110000Z
DTEND:20251027T120000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:c1eeaad7-bfb8-4b64-bdcc-f509934712b5
DTSTAMP:20250924T210622Z
DTSTART:20251027T120000Z
DTEND:20251027T130000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:43c54ab3-d82f-4d41-9baf-a830116e8de4
DTSTAMP:20250924T210622Z
DTSTART:20251030T120000Z
DTEND:20251030T130000Z
SUMMARY:PK 3.6 Introduction to topics for Thursday PM  Joint Drug devt and PK
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:c746146a-125e-4150-92ef-fe3f5033eef1
DTSTAMP:20250924T210622Z
DTSTART:20251030T140000Z
DTEND:20251030T150000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:0b37bd3b-1e37-45bd-a36a-43bc5fa7a881
DTSTAMP:20250924T210622Z
DTSTART:20251030T150000Z
DTEND:20251030T160000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:aa730509-b898-4b6a-953d-9e3cf2dda43f
DTSTAMP:20250924T210622Z
DTSTART:20251113T100000Z
DTEND:20251113T110000Z
SUMMARY:PK and drug development assignment drop in session
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Ateeq
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:f62e9b33-e6d5-4e3d-8091-6aeb686c2bd4
DTSTAMP:20250924T210622Z
DTSTART:20251113T110000Z
DTEND:20251113T120000Z
SUMMARY:PK 3.8 Pharmacogenomics
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:ebc84b3c-39b3-4f98-b956-6dc426a8a101
DTSTAMP:20250924T210622Z
DTSTART:20251113T120000Z
DTEND:20251113T130000Z
SUMMARY:PK 3.9 Bioequivalence 2
DESCRIPTION:Module - PHA503, Person delivering - Toqa
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:c997c13b-d5f1-44fe-90ed-ae85918b7d3e
DTSTAMP:20250924T210622Z
DTSTART:20251205T140000Z
DTEND:20251205T150000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - ?Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:2d1fd95d-4c85-40ec-8640-4bafeb826b56
DTSTAMP:20250924T210622Z
DTSTART:20251208T100000Z
DTEND:20251208T110000Z
SUMMARY:PK 3.11 Pharmacokinetic Variability and Assignment Debrief
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Toqa, Ateeq, Dan
LOCATION:Lecture theatre A
END:VEVENT
BEGIN:VEVENT
UID:9a55d02f-6931-43f5-9be8-22d95d1c36f3
DTSTAMP:20250924T210622Z
DTSTART:20260108T140000Z
DTEND:20260108T150000Z
SUMMARY:PK 3.12  Introduction to PK modelling
DESCRIPTION:Module - PHA503, Person delivering - Prof. Joe Standing
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:8831099d-b345-4b39-9c55-cee4a396691e
DTSTAMP:20250924T210622Z
DTSTART:20260108T150000Z
DTEND:20260108T160000Z
SUMMARY:PK 3.13  Introduction to Compartmental analysis
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:TBC
END:VEVENT
END:VCALENDAR
